These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 24809472)
1. The deficiency of tumor suppressor prep1 accelerates the onset of meis1- hoxa9 leukemogenesis. Dardaei L; Modica L; Iotti G; Blasi F PLoS One; 2014; 9(5):e96711. PubMed ID: 24809472 [TBL] [Abstract][Full Text] [Related]
2. C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein. Bisaillon R; Wilhelm BT; Krosl J; Sauvageau G Blood; 2011 Oct; 118(17):4682-9. PubMed ID: 21900201 [TBL] [Abstract][Full Text] [Related]
3. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Wang GG; Pasillas MP; Kamps MP Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484 [TBL] [Abstract][Full Text] [Related]
4. Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis. Dardaei L; Longobardi E; Blasi F Proc Natl Acad Sci U S A; 2014 Mar; 111(10):E896-905. PubMed ID: 24578510 [TBL] [Abstract][Full Text] [Related]
5. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus. Wang GG; Pasillas MP; Kamps MP Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900 [TBL] [Abstract][Full Text] [Related]
6. MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance. Rosales-Aviña JA; Torres-Flores J; Aguilar-Lemarroy A; Gurrola-Díaz C; Hernández-Flores G; Ortiz-Lazareno PC; Lerma-Díaz JM; de Celis R; González-Ramella Ó; Barrera-Chaires E; Bravo-Cuellar A; Jave-Suárez LF J Exp Clin Cancer Res; 2011 Dec; 30(1):112. PubMed ID: 22185299 [TBL] [Abstract][Full Text] [Related]
7. A tale of TALE, PREP1, PBX1, and MEIS1: Interconnections and competition in cancer. Blasi F; Bruckmann C; Penkov D; Dardaei L Bioessays; 2017 May; 39(5):. PubMed ID: 28322463 [TBL] [Abstract][Full Text] [Related]
8. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease. Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896 [TBL] [Abstract][Full Text] [Related]
9. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Thorsteinsdottir U; Kroon E; Jerome L; Blasi F; Sauvageau G Mol Cell Biol; 2001 Jan; 21(1):224-34. PubMed ID: 11113197 [TBL] [Abstract][Full Text] [Related]
10. Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia. He M; Chen P; Arnovitz S; Li Y; Huang H; Neilly MB; Wei M; Rowley JD; Chen J; Li Z Blood Cells Mol Dis; 2012 Aug; 49(2):102-6. PubMed ID: 22633751 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice. Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578 [TBL] [Abstract][Full Text] [Related]
12. Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc. Garcia-Cuellar MP; Prinz A; Slany RK Haematologica; 2022 Nov; 107(11):2601-2616. PubMed ID: 35546301 [TBL] [Abstract][Full Text] [Related]
13. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation. Morgado E; Albouhair S; Lavau C Blood; 2007 May; 109(9):4020-2. PubMed ID: 17202314 [TBL] [Abstract][Full Text] [Related]
15. Tumorigenesis by Meis1 overexpression is accompanied by a change of DNA target-sequence specificity which allows binding to the AP-1 element. Dardaei L; Penkov D; Mathiasen L; Bora P; Morelli MJ; Blasi F Oncotarget; 2015 Sep; 6(28):25175-87. PubMed ID: 26259236 [TBL] [Abstract][Full Text] [Related]
17. HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis. Hu YL; Fong S; Ferrell C; Largman C; Shen WF Mol Cell Biol; 2009 Sep; 29(18):5181-92. PubMed ID: 19620287 [TBL] [Abstract][Full Text] [Related]
18. Hypomorphic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype. Ferretti E; Villaescusa JC; Di Rosa P; Fernandez-Diaz LC; Longobardi E; Mazzieri R; Miccio A; Micali N; Selleri L; Ferrari G; Blasi F Mol Cell Biol; 2006 Aug; 26(15):5650-62. PubMed ID: 16847320 [TBL] [Abstract][Full Text] [Related]
19. Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines. Wermuth PJ; Buchberg AM Blood; 2005 Feb; 105(3):1222-30. PubMed ID: 15479723 [TBL] [Abstract][Full Text] [Related]
20. HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. Shen WF; Rozenfeld S; Kwong A; Köm ves LG; Lawrence HJ; Largman C Mol Cell Biol; 1999 Apr; 19(4):3051-61. PubMed ID: 10082572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]